Influence of chronic pain in osteoarthritis on the risk of cardiovascular diseases and modern methods of drug prevention
The purpose of the review of scientific medical literature was to evaluate the data of the epidemiology of osteoarthritis (OA) and cardiovascular diseases (CVD) with the analysis of risk factors, pathophysiological and pathobiochemical mechanisms of the relationship between OA and the risk of developing CVD in the presence of chronic pain, modern strategies for screening and management of this cohort of patients, the mechanism of action and pharmacological effects of chondroitin sulfate (CS). Conclusions were drawn about the need for additional clinical and observational studies of the efficacy and safety of the parenteral form of CS (Chondroguard) in patients with chronic pain in OA and CVD, improvement of clinical recommendations for the treatment of chronic pain in patients with OA and cardiovascular risk, with special attention to interventions that eliminate mobility restrictions in patients and the inclusion of basic and adjuvant therapy with DMOADs to achieve the goals of multipurpose monotherapy in patients with contraindications to standard therapy drugs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:123 |
|---|---|
| Enthalten in: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 123(2023), 5 vom: 23., Seite 20-30 |
| Sprache: |
Russisch |
|---|
| Weiterer Titel: |
Vliyanie khronicheskoi boli pri osteoartrite na risk razvitiya serdechno-sosudistykh zabolevanii i sovremennye sposoby ikh lekarstvennoi profilaktiki |
|---|
| Beteiligte Personen: |
Sarvilina, I V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9007-28-7 |
|---|
| Anmerkungen: |
Date Completed 16.06.2023 Date Revised 16.06.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17116/jnevro202312305120 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358168724 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358168724 | ||
| 003 | DE-627 | ||
| 005 | 20231226074154.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.17116/jnevro202312305120 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM358168724 | ||
| 035 | |a (NLM)37315238 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Sarvilina, I V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Influence of chronic pain in osteoarthritis on the risk of cardiovascular diseases and modern methods of drug prevention |
| 246 | 3 | 3 | |a Vliyanie khronicheskoi boli pri osteoartrite na risk razvitiya serdechno-sosudistykh zabolevanii i sovremennye sposoby ikh lekarstvennoi profilaktiki |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.06.2023 | ||
| 500 | |a Date Revised 16.06.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The purpose of the review of scientific medical literature was to evaluate the data of the epidemiology of osteoarthritis (OA) and cardiovascular diseases (CVD) with the analysis of risk factors, pathophysiological and pathobiochemical mechanisms of the relationship between OA and the risk of developing CVD in the presence of chronic pain, modern strategies for screening and management of this cohort of patients, the mechanism of action and pharmacological effects of chondroitin sulfate (CS). Conclusions were drawn about the need for additional clinical and observational studies of the efficacy and safety of the parenteral form of CS (Chondroguard) in patients with chronic pain in OA and CVD, improvement of clinical recommendations for the treatment of chronic pain in patients with OA and cardiovascular risk, with special attention to interventions that eliminate mobility restrictions in patients and the inclusion of basic and adjuvant therapy with DMOADs to achieve the goals of multipurpose monotherapy in patients with contraindications to standard therapy drugs | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a atherosclerosis | |
| 650 | 4 | |a cardiovascular risk | |
| 650 | 4 | |a chondroitin sulfate | |
| 650 | 4 | |a chronic pain | |
| 650 | 4 | |a dorsalgia | |
| 650 | 4 | |a osteoarthritis | |
| 650 | 4 | |a thromboembolism | |
| 650 | 7 | |a Chondroitin Sulfates |2 NLM | |
| 650 | 7 | |a 9007-28-7 |2 NLM | |
| 700 | 1 | |a Danilov, Al B |e verfasserin |4 aut | |
| 700 | 1 | |a Tkacheva, O N |e verfasserin |4 aut | |
| 700 | 1 | |a Gromova, O A |e verfasserin |4 aut | |
| 700 | 1 | |a Solovieva, E Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Dudinskaya, E N |e verfasserin |4 aut | |
| 700 | 1 | |a Rozanov, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Kartashova, E A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova |d 1997 |g 123(2023), 5 vom: 23., Seite 20-30 |w (DE-627)NLM074605267 |x 1997-7298 |7 nnns |
| 773 | 1 | 8 | |g volume:123 |g year:2023 |g number:5 |g day:23 |g pages:20-30 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17116/jnevro202312305120 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 123 |j 2023 |e 5 |b 23 |h 20-30 | ||